Merit Medical Systems Inc
MMSI87.390USD
-0.240-0.27%
Close 12/24, 16:00（ET）Quotes delayed by 15 min
5.18BMarket Cap
43.52P/E TTM
More Details of Merit Medical Systems Inc Company
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Merit Medical Systems Inc Info
Ticker SymbolMMSI
Company nameMerit Medical Systems Inc
IPO dateOct 22, 2090
CEOAronson (Martha Goldberg)
Number of employees7400
Security typeOrdinary Share
Fiscal year-endOct 22
Address1600 West Merit Park Way
CitySOUTH JORDAN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code84095
Phone18012531600
Websitehttps://www.merit.com/
Ticker SymbolMMSI
IPO dateOct 22, 2090
CEOAronson (Martha Goldberg)
Company Executives of Merit Medical Systems Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
By RegionUSD
Name
Revenue
Proportion
United States
227.08M
59.37%
International
155.38M
40.63%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Other
64.97%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Other
64.97%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.11%
Investment Advisor/Hedge Fund
32.95%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.31%
Individual Investor
2.26%
Pension Fund
1.63%
Sovereign Wealth Fund
1.02%
Family Office
0.40%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Nomura Investment Management Business Trust
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Institutional Asset Management
1.09M
1.85%
-3.11K
-0.28%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.18%
First Trust Indxx Medical Devices ETF
Proportion2.22%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.76%
Thrivent Small-Mid Cap ESG ETF
Proportion0.91%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.71%
OneAscent Enhanced Small and Mid Cap ETF
Proportion0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.67%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.66%
Franklin US Small Cap Multifactor Index ETF
Proportion0.66%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Merit Medical Systems Inc?
The top five shareholders of Merit Medical Systems Inc are:
BlackRock Institutional Trust Company, N.A. holds 7.97M shares, accounting for 13.46% of the total shares.
The Vanguard Group, Inc. holds 6.82M shares, accounting for 11.51% of the total shares.
State Street Investment Management (US) holds 2.22M shares, accounting for 3.75% of the total shares.
Conestoga Capital Advisors, LLC holds 2.21M shares, accounting for 3.73% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.82M shares, accounting for 3.07% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 7.97M shares, accounting for 13.46% of the total shares.
The Vanguard Group, Inc. holds 6.82M shares, accounting for 11.51% of the total shares.
State Street Investment Management (US) holds 2.22M shares, accounting for 3.75% of the total shares.
Conestoga Capital Advisors, LLC holds 2.21M shares, accounting for 3.73% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.82M shares, accounting for 3.07% of the total shares.
What are the top three shareholder types of Merit Medical Systems Inc?
The top three shareholder types of Merit Medical Systems Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
How many institutions hold shares of Merit Medical Systems Inc (MMSI)?
As of 2025Q3, 736 institutions hold shares of Merit Medical Systems Inc, with a combined market value of approximately 64.29M, accounting for 108.43% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.37%.
What is the biggest source of revenue for Merit Medical Systems Inc?
In FY2025Q2, the Peripheral Intervention business generated the highest revenue for Merit Medical Systems Inc, amounting to 142.85M and accounting for 37.35% of total revenue.
